Sanjivani Paranteral Ltd.

View in App
135.25 -2.75 ▼-2.0%

07 December 2023, 04:01:00 PM
Volume: 4,259

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sanjivani.co.in
Market Cap 135.28 Cr.
Enterprise Value(EV) 138.66 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 5.20 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 26.00 Trailing Twelve Months Ending 2023-09
Industry PE 38.59 Trailing Twelve Months Ending 2023-09
Book Value / Share 0.18 Trailing Twelve Months Ending 2023-09
Price to Book Value 735.73 Calculated using Price: 135.30
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.00 Cr. 9,998,300 Shares
FaceValue 10
About Sanjivani Paranteral Ltd.
Sanjivani Parenteral was established in 1997 by A H Khemka, Ashwin Khemka and Somesh Khemka, under the technical direction of Mahendra Kalwankar. It is a research-based, international pharmaceutical company that provides a wide range of high quality products and services at affordable prices. The core product range of the company's products includes oral solids, small volume parenterals and sterile powder formulations.

Sanjivani Paranteral Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Sanjivani Paranteral Ltd. Performance

View details >>
1 Day
-1.99%
1 Week
-1.99%
1 Month
+6.45%
3 Month
+43.88%
6 Month
+89.61%
1 Year
+238.97%
2 Year
+383.04%
5 Year
+3198.78%
10 Year
+1036.55%

Sanjivani Paranteral Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -7.19 -58.98 -596.93
Return on Capital Employed (%) 5.69 -7.28 -33.04 -227.28 -265.98 266.43
Return on Assets (%) -2.09 -14.16 -34.18 -124.34 -9.62 -10.16 8.13 25.80 22.96

Sanjivani Paranteral Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 32 18 -9 -53 -47 -49 -45 -8 -3 0
Non Curr. Liab. 7 14 9 6 10 9 7 4 1 1
Curr. Liab. 75 62 61 72 56 55 58 22 23 23
Minority Int.
Equity & Liab. 114 93 60 25 18 16 19 18 21 24
Non Curr. Assets 16 23 17 16 11 12 10 11 13 11
Curr. Assets 98 70 43 9 7 4 9 8 8 14
Misc. Exp. not W/O
Total Assets 114 93 60 25 18 16 19 18 21 24

Sanjivani Paranteral Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 133 115 33 18 25 16 25 31 35 44
Other Income 1 1 3 0 1 0 0 2 1 0
Total Income 135 116 36 18 26 17 25 32 36 44
Total Expenditure -128 -121 -56 -70 -27 -17 -23 -26 -30 -37
PBIDT 7 -5 -20 -52 -1 0 2 6 6 7
Interest -8 -9 -5 0 0 -1 0 0 0 0
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation 0 0 0 0 0 0 0 0 0 -1
Exceptional Items 0
PAT -2 -15 -26 -53 -2 -2 1 5 5 5
Adjusted EPS -4 -25 -44 -90 -4 -3 2 5 5 5

Sanjivani Paranteral Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 9 -1 0 10 3 2 0 1 9 5
Cash Fr. Inv. -1 9 -1 0 0 0 0 0 -1 -1
Cash Fr. Finan. -8 -7 -1 -10 -3 -2 0 0 -8 -4
Net Change 0 0 -1 0 0 0 0 0 0 0
Cash & Cash Eqvt 1 1 0 0 0 0 0 0 0

Sanjivani Paranteral Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 19.85 27.35 27.35 27.35 27.35 27.35 29.88 31.70 32.34
Public 80.15 72.65 72.65 72.65 72.65 72.65 70.12 68.30 67.66
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Sanjivani Paranteral Ltd. Announcements

View details >>
Wed, 22 Nov 2023
Announcement under Regulation 30 (LODR)-Investor Presentation
Revised Investor Presentation of Sanjivani Paranteral Limited highlighting the performance of the Company during the quarter and Half Year ended on September 30 2023
Fri, 17 Nov 2023
Announcement under Regulation 30 (LODR)-Investor Presentation
Revised Investor Presentation of Sanjivani Paranteral Limited highlighting the performance of the Company during the quarter and half year ended on September 30 2023.
Wed, 25 Oct 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Earnings Call with the Investors and Analysists conducted on October 19 2023 for the second quarter ended September 30 2023.

Sanjivani Paranteral Ltd. Technical Scans

View details >>
Wed, 06 Dec 2023
Opening at Low Opening at Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Sanjivani Paranteral Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 297,505.54 1,239.50 0.0%
Divi's Laboratories Ltd. 99,176.41 3,735.00 0.0%
Cipla Ltd. 97,326.09 1,222.90 +1.4%
Dr. Reddy's Laboratories Ltd. 95,542.33 5,780.15 +0.9%
Apollo Hospitals Enterprise Ltd. 79,692.65 5,460.50 -1.5%
Mankind Pharma Ltd. 78,212.89 1,997.90 +2.3%
Torrent Pharmaceuticals Ltd. 70,379.73 2,104.30 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.80 1,239.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-09 74.47 3,735.00 0.0%
Cipla Ltd. Consolidated 2023-09 28.18 1,222.90 +1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.77 5,780.15 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.26 5,460.50 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 61.02 1,997.90 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.76 2,104.30 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.97 1,239.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-09 7.82 3,735.00 0.0%
Cipla Ltd. Consolidated 2023-09 3.92 1,222.90 +1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.75 5,780.15 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.26 5,460.50 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 9.28 1,997.90 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.49 2,104.30 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,239.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,735.00 0.0%
Cipla Ltd. Consolidated 2023-03 0.02 1,222.90 +1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,780.15 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,460.50 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,997.90 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,104.30 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,239.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,735.00 0.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,222.90 +1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,780.15 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,460.50 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,997.90 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,104.30 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,239.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,735.00 0.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,222.90 +1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,780.15 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,460.50 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,997.90 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,104.30 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,239.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,735.00 0.0%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,222.90 +1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,780.15 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,460.50 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,997.90 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,104.30 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,239.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,735.00 0.0%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,222.90 +1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,780.15 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,460.50 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,997.90 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,104.30 +1.2%

Sanjivani Paranteral Ltd. FAQ's

What is Sanjivani Paranteral share price?
Can I buy Sanjivani Paranteral shares now?
What is the Market Cap of Sanjivani Paranteral?
What are the key metrics to analyse Sanjivani Paranteral?
What is the 52 Week High and Low of Sanjivani Paranteral?
What is the trend of Sanjivani Paranteral share price?